Latest statistics and disclosures from Corriente Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Reata Pharmaceuticals Inc Cl A stock, Maxar Technologies Inc, Aptose Biosciences, Cue Biopharma Inc, Grayscale Bitcoin Ord, and represent 84.88% of Corriente Advisors's stock portfolio.
- Added to shares of these 8 stocks: Aptose Biosciences (+$14.64M), Cue Biopharma Inc (+$7.59M), Grayscale Bitcoin Ord, Pieris Pharmaceuticals, Epizyme, Schrodinger Inc Com stock, Sunesis Pharmaceuticals Inc Ne, TSLA.
- Started 6 new stock positions in Schrodinger Inc Com stock, TSLA, Sunesis Pharmaceuticals Inc Ne, Grayscale Bitcoin Ord, Pieris Pharmaceuticals, Epizyme.
- Reduced shares in these 10 stocks: Virgin Galactic Holdings Inc virgin galactic holdings inc (-$27.86M), Uniqure Nv shs (-$18.09M), Turning Point Therapeutics I (-$17.75M), Intelsat Sa (-$11.47M), Maxar Technologies Inc (-$10.61M), Catabasis Pharmaceuticals Ord, Global Blood Therapeutics In, Eiger Biopharmaceuticals, Virgin Galactic Holdings Inc virgin galactic holding-cw22, Equinox Gold Corp equities.
- Sold out of its positions in Catabasis Pharmaceuticals Ord, DIS, Eiger Biopharmaceuticals, Equinox Gold Corp equities, Global Blood Therapeutics In, GFI, Rocket Pharmaceuticals Inc, Turning Point Therapeutics I, Virgin Galactic Holdings Inc virgin galactic holdings inc, Virgin Galactic Holdings Inc virgin galactic holding-cw22. Intelsat Sa, Uniqure Nv shs.
- Corriente Advisors was a net seller of stock by $68.77M.
- Corriente Advisors has $92.64M in assets under management (AUM), dropping by -50.24%.
Portfolio Holdings for Corriente Advisors
Companies in the Corriente Advisors portfolio as of the March 2020 quarterly 13F filing
|Company (Ticker)||Portfolio Weight||Share Count||Change in Shares||Price|
|Reata Pharmaceuticals Inc Cl A stock||29.60||190000||144.34|
|Maxar Technologies Inc||19.47||1.69M||-37%||10.68|
|Cue Biopharma Inc||12.56||820000||+187%||14.19|
|Grayscale Bitcoin Ord||4.53||590000||NEW||7.12|
|Schrodinger Inc Com stock||2.79||60000||NEW||43.12|
|Bellus Health Inc New||1.60||148666||-32%||9.98|
|Sunesis Pharmaceuticals Inc Ne||1.35||3.02M||NEW||0.41|
|Tesla Motors (TSLA)||1.13||2000||NEW||524.00|
Past Filings by Corriente Advisors
View past SEC 13F filings by Corriente Advisors
- Corriente Advisors 2019 Q4 filed Feb. 14, 2020
- Corriente Advisors 2013 Q3 filed Nov. 14, 2013
- Corriente Advisors 2013 Q2 filed Aug. 14, 2013
- Corriente Advisors 2012 Q4 filed Feb. 14, 2013
- Corriente Advisors 2012 Q3 filed Nov. 14, 2012
- Corriente Advisors 2012 Q1 filed May 15, 2012
- Corriente Advisors 2011 Q4 filed Feb. 14, 2012
- Corriente Advisors 2011 Q3 filed Nov. 14, 2011
- Corriente Advisors 2011 Q2 filed Aug. 15, 2011
- Corriente Advisors 2011 Q1 filed May 16, 2011
- Corriente Advisors 2010 Q4 filed Feb. 14, 2011